CD276 as a novel CAR NK‐92 therapeutic target for neuroblastoma
ADVANCES IN CELL AND GENE THERAPY · 2021
DOI: 10.1002/acg2.105 ↗Kurz gefasst
Fachartikel in der Zeitschrift ADVANCES IN CELL AND GENE THERAPY, 2021. Verfasst von Stefan Grote und 8 weiteren Autor:innen. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Grote, S., Chan, K. C., Baden, C., Bösmüller, H., Sulyok, M., Frauenfeld, L., Ebinger, M., Handgretinger, R., & Schleicher, S. (2021). CD276 as a novel CAR NK‐92 therapeutic target for neuroblastoma. ADVANCES IN CELL AND GENE THERAPY. https://doi.org/10.1002/acg2.105
Vancouver
Grote S, Chan KC, Baden C, Bösmüller H, Sulyok M, Frauenfeld L, et al. CD276 as a novel CAR NK‐92 therapeutic target for neuroblastoma. ADVANCES IN CELL AND GENE THERAPY. 2021. doi:10.1002/acg2.105
BibTeX
@article{Grote2021,
author = {Grote, Stefan and Chan, Kenneth Chun‐Ho and Baden, Caroline and Bösmüller, Hans and Sulyok, Mihály and Frauenfeld, Leonie and Ebinger, Martin and Handgretinger, Rupert and Schleicher, Sabine},
title = {CD276 as a novel CAR NK‐92 therapeutic target for neuroblastoma},
journal = {ADVANCES IN CELL AND GENE THERAPY},
year = {2021},
doi = {10.1002/acg2.105}
}
EUVIMED